Eikon Therapeutics

IPO initial public offering
Biotech

Eikon plans IPO to bankroll clutch of clinical cancer drugs

Eikon is planning to become the second biotech to go public in 2026 in another sign the public markets are looking attractive to drug developers.
James Waldron Jan 12, 2026 4:40am
Conceptual illustration of layoffs featuring rows of translucent human figures overlaid with large blue scissors symbolizing

Biopharma layoffs hit 4-year monthly high in May

Jul 8, 2025 2:26pm
A series of dice with a bag on them illustrating cost cuts

Eikon blames US cuts for 15% staff reduction

May 22, 2025 7:55am
money dollar sign fundraise market

Eikon remains in megaround mode with $350M series D

Feb 26, 2025 9:40am
parachute sun mountain sunrise

Pfizer replaces retiring CSO with cancer chief—Chutes & Ladders

Nov 22, 2024 8:30am
money bank piggybank

Eikon, Dewpoint investors raise new $630 million fund

Jan 29, 2024 9:39am